메뉴 건너뛰기




Volumn 26, Issue 17, 2012, Pages 2165-2174

Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA

Author keywords

HIV; lipoatrophy; lopinavir; mitochondrial DNA; nevirapine; zidovudine

Indexed keywords

ABACAVIR; ATAZANAVIR; CHOLESTEROL; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOCHONDRIAL DNA; NEVIRAPINE; TENOFOVIR; TRIACYLGLYCEROL; ZIDOVUDINE;

EID: 84869504030     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328358b279     Document Type: Article
Times cited : (14)

References (34)
  • 1
    • 84870804978 scopus 로고    scopus 로고
    • European AIDS Clinical Society, [Accessed 30 October 2011]
    • European AIDS Clinical Society. Guidelines Version 6. http://europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/eacsguidelines- 6. Df. [Accessed 30 October 2011].
    • Guidelines Version 6.
  • 2
    • 77954692660 scopus 로고    scopus 로고
    • Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel
    • Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010; 304:321-333.
    • (2010) JAMA , vol.304 , pp. 321-333
    • Thompson, M.A.1    Aberg, J.A.2    Cahn, P.3    Montaner, J.S.4    Rizzardini, G.5    Telenti, A.6
  • 3
    • 0034457885 scopus 로고    scopus 로고
    • HIV protease inhibitor-related lipodystrophy syndrome
    • Carr A. HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis 2000; 30 (Suppl 2):S135-S142.
    • (2000) Clin Infect Dis , vol.30 , Issue.SUPPL. 2
    • Carr, A.1
  • 4
    • 0037032941 scopus 로고    scopus 로고
    • Increased risk of lipoatrophy under stavudine in HIV-1- infected patients: Results of a substudy from a comparative trial
    • Joly V, Flandre P, Meiffredy V, Leturque N, Harel M, Aboulker JP, et al. Increased risk of lipoatrophy under stavudine in HIV-1- infected patients: results of a substudy from a comparative trial. AIDS 2002; 16:2447-2454.
    • (2002) AIDS , vol.16 , pp. 2447-2454
    • Joly, V.1    Flandre, P.2    Meiffredy, V.3    Leturque, N.4    Harel, M.5    Aboulker, J.P.6
  • 6
    • 2042439088 scopus 로고    scopus 로고
    • Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6-12 months of commencing nucleoside reverse transcriptase inhibitor therapy
    • Hammond E, Nolan D, James I, Metcalf C, Mallal S. Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6-12 months of commencing nucleoside reverse transcriptase inhibitor therapy. AIDS 2004; 18:815-817.
    • (2004) AIDS , vol.18 , pp. 815-817
    • Hammond, E.1    Nolan, D.2    James, I.3    Metcalf, C.4    Mallal, S.5
  • 7
    • 49949117158 scopus 로고    scopus 로고
    • Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection
    • McComsey GA, Libutti DE, Oriordan M, Shelton JM, Storer N, Ganz J, et al. Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection. Antivir Ther 2008; 13:715-722.
    • (2008) Antivir Ther , vol.13 , pp. 715-722
    • McComsey, G.A.1    Libutti, D.E.2    Oriordan, M.3    Shelton, J.M.4    Storer, N.5    Ganz, J.6
  • 8
    • 80052099398 scopus 로고    scopus 로고
    • Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy
    • Sevastianova K, Sutinen J, Greco D, Sievers M, Salmenkivi K, Perttila J, et al. Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy. Diabetes 2011; 60:1894-1900.
    • (2011) Diabetes , vol.60 , pp. 1894-1900
    • Sevastianova, K.1    Sutinen, J.2    Greco, D.3    Sievers, M.4    Salmenkivi, K.5    Perttila, J.6
  • 9
    • 0037999080 scopus 로고    scopus 로고
    • Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy
    • Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, et al. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 2003; 17:1329- 1338.
    • (2003) AIDS , vol.17 , pp. 1329-1338
    • Nolan, D.1    Hammond, E.2    Martin, A.3    Taylor, L.4    Herrmann, S.5    McKinnon, E.6
  • 10
    • 0035964717 scopus 로고    scopus 로고
    • Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy
    • Shikuma CM, Hu N, Milne C, Yost F, Waslien C, Shimizu S, et al. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS 2001; 15:1801-1809.
    • (2001) AIDS , vol.15 , pp. 1801-1809
    • Shikuma, C.M.1    Hu, N.2    Milne, C.3    Yost, F.4    Waslien, C.5    Shimizu, S.6
  • 11
    • 7644244886 scopus 로고    scopus 로고
    • Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: A randomized, double-blind, placebo-controlled pilot study
    • Rabing Christensen E, Stegger M, Jensen-Fangel S, Laursen AL, Ostergaard L. Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study. Clin Infect Dis 2004; 39:1371-1379.
    • (2004) Clin Infect Dis , vol.39 , pp. 1371-1379
    • Rabing Christensen, E.1    Stegger, M.2    Jensen-Fangel, S.3    Laursen, A.L.4    Ostergaard, L.5
  • 12
    • 3042734983 scopus 로고    scopus 로고
    • Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy
    • van der Valk M, Casula M, Weverlingz GJ, van Kuijk K, van Eck- Smit B, Hulsebosch HJ, et al. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy. Antivir Ther 2004; 9:385-393.
    • (2004) Antivir Ther , vol.9 , pp. 385-393
    • Van Der Valk, M.1    Casula, M.2    Weverlingz, G.J.3    Van Kuijk, K.4    Van Eck- Smit, B.5    Hulsebosch, H.J.6
  • 13
    • 33748103186 scopus 로고    scopus 로고
    • Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
    • Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Antivir Ther 2006; 11:601-608.
    • (2006) Antivir Ther , vol.11 , pp. 601-608
    • Maagaard, A.1    Holberg-Petersen, M.2    Kollberg, G.3    Oldfors, A.4    Sandvik, L.5    Bruun, J.N.6
  • 14
    • 77949556554 scopus 로고    scopus 로고
    • Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: Implications for the pathogenesis of the disease
    • Pinti M, Gibellini L, Guaraldi G, Orlando G, Gant TW, Morselli E, et al. Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease. AIDS 2010; 24:841-850.
    • (2010) AIDS , vol.24 , pp. 841-850
    • Pinti, M.1    Gibellini, L.2    Guaraldi, G.3    Orlando, G.4    Gant, T.W.5    Morselli, E.6
  • 15
    • 0032493043 scopus 로고    scopus 로고
    • A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
    • Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12:F51-F58.
    • (1998) AIDS , vol.12
    • Carr, A.1    Samaras, K.2    Burton, S.3    Law, M.4    Freund, J.5    Chisholm, D.J.6
  • 16
    • 0032537042 scopus 로고    scopus 로고
    • Indinavir-associated lipodystrophy
    • Viraben R, Aquilina C. Indinavir-associated lipodystrophy. AIDS 1998; 12:F37-F39.
    • (1998) AIDS , vol.12
    • Viraben, R.1    Aquilina, C.2
  • 17
    • 0033583977 scopus 로고    scopus 로고
    • Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
    • Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999; 353:2093- 2099.
    • (1999) Lancet , vol.353 , pp. 2093-2099
    • Carr, A.1    Samaras, K.2    Thorisdottir, A.3    Kaufmann, G.R.4    Chisholm, D.J.5    Cooper, D.A.6
  • 18
    • 79957953991 scopus 로고    scopus 로고
    • Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines
    • Gallego-Escuredo JM, Del Mar Gutierrez M, Diaz-Delfin J, Domingo JC, Mateo MG, Domingo P, et al. Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines. Curr HIV Res 2010; 8:545-553.
    • (2010) Curr HIV Res , vol.8 , pp. 545-553
    • Gallego-Escuredo, J.M.1    Del Mar Gutierrez, M.2    Diaz-Delfin, J.3    Domingo, J.C.4    Mateo, M.G.5    Domingo, P.6
  • 19
    • 0034987343 scopus 로고    scopus 로고
    • The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance
    • Caron M, Auclair M, Vigouroux C, Glorian M, Forest C, Capeau J. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 2001; 50:1378-1388.
    • (2001) Diabetes , vol.50 , pp. 1378-1388
    • Caron, M.1    Auclair, M.2    Vigouroux, C.3    Glorian, M.4    Forest, C.5    Capeau, J.6
  • 20
    • 0034731520 scopus 로고    scopus 로고
    • Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors
    • Dowell P, Flexner C, Kwiterovich PO, Lane MD. Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors. J Biol Chem 2000; 275:41325- 41332.
    • (2000) J Biol Chem , vol.275 , pp. 41325-41332
    • Dowell, P.1    Flexner, C.2    Kwiterovich, P.O.3    Lane, M.D.4
  • 22
    • 11144357775 scopus 로고    scopus 로고
    • Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a nonnucleoside reverse transcriptase inhibitor
    • Solas C, Poizot-Martin I, Drogoul MP, Ravaux I, Dhiver C, Lafeuillade A, et al. Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a nonnucleoside reverse transcriptase inhibitor. Br J Clin Pharmacol 2004; 57:436-440.
    • (2004) Br J Clin Pharmacol , vol.57 , pp. 436-440
    • Solas, C.1    Poizot-Martin, I.2    Drogoul, M.P.3    Ravaux, I.4    Dhiver, C.5    Lafeuillade, A.6
  • 23
    • 20844435624 scopus 로고    scopus 로고
    • In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA
    • Mallon PW, Unemori P, Sedwell R, Morey A, Rafferty M, Williams K, et al. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J Infect Dis 2005; 191:1686-1696.
    • (2005) J Infect Dis , vol.191 , pp. 1686-1696
    • Mallon, P.W.1    Unemori, P.2    Sedwell, R.3    Morey, A.4    Rafferty, M.5    Williams, K.6
  • 24
    • 19944426227 scopus 로고    scopus 로고
    • Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine
    • McComsey GA, Paulsen DM, Lonergan JT, Hessenthaler SM, Hoppel CL, Williams VC, et al. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS 2005; 19:15-23.
    • (2005) AIDS , vol.19 , pp. 15-23
    • McComsey, G.A.1    Paulsen, D.M.2    Lonergan, J.T.3    Hessenthaler, S.M.4    Hoppel, C.L.5    Williams, V.C.6
  • 25
    • 65749093276 scopus 로고    scopus 로고
    • Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovircontaining regimen
    • Gerschenson M, Kim C, Berzins B, Taiwo B, Libutti DE, Choi J, et al. Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovircontaining regimen. J Antimicrob Chemother 2009; 63:1244- 1250.
    • (2009) J Antimicrob Chemother , vol.63 , pp. 1244-1250
    • Gerschenson, M.1    Kim, C.2    Berzins, B.3    Taiwo, B.4    Libutti, D.E.5    Choi, J.6
  • 26
    • 34250648975 scopus 로고    scopus 로고
    • Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults
    • Fleischman A, Johnsen S, Systrom DM, Hrovat M, Farrar CT, Frontera W, et al. Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. Am J Physiol Endocrinol Metab 2007; 292:E1666-E1673.
    • (2007) Am J Physiol Endocrinol Metab , vol.292
    • Fleischman, A.1    Johnsen, S.2    Systrom, D.M.3    Hrovat, M.4    Farrar, C.T.5    Frontera, W.6
  • 27
    • 34548084819 scopus 로고    scopus 로고
    • Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384
    • Dube MP, Komarow L, Mulligan K, Grinspoon SK, Parker RA, Robbins GK, et al. Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384. J Acquir Immune Defic Syndr 2007; 45: 508-514.
    • (2007) J Acquir Immune Defic Syndr , vol.45 , pp. 508-514
    • Dube, M.P.1    Komarow, L.2    Mulligan, K.3    Grinspoon, S.K.4    Parker, R.A.5    Robbins, G.K.6
  • 28
    • 0038708272 scopus 로고    scopus 로고
    • Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
    • Mallon PW, Miller J, Cooper DA, Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS 2003; 17:971- 979.
    • (2003) AIDS , vol.17 , pp. 971-979
    • Mallon, P.W.1    Miller, J.2    Cooper, D.A.3    Carr, A.4
  • 29
    • 34447565930 scopus 로고    scopus 로고
    • Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen
    • Cameron DW, Becker S, King MS, da Silva B, Klein C, Tokimoto D, et al. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. J Antimicrob Chemother 2007; 59:957-963.
    • (2007) J Antimicrob Chemother , vol.59 , pp. 957-963
    • Cameron, D.W.1    Becker, S.2    King, M.S.3    Da Silva, B.4    Klein, C.5    Tokimoto, D.6
  • 30
    • 30444452551 scopus 로고    scopus 로고
    • In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis
    • Miro O, Villarroya J, Garrabou G, Lopez S, Rodriguez de la Concepcion M, Pedrol E, et al. In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis. Antivir Ther 2005; 10:945-951.
    • (2005) Antivir Ther , vol.10 , pp. 945-951
    • Miro, O.1    Villarroya, J.2    Garrabou, G.3    Lopez, S.4    De La Concepcion, M.R.5    Pedrol, E.6
  • 31
    • 3943095878 scopus 로고    scopus 로고
    • Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir
    • Hoy J, Gahan M, Carr A, Smith D, Lewin S, Wesselingh S, et al. Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir. J Infect Dis 2004; 190:688- 692.
    • (2004) J Infect Dis , vol.190 , pp. 688-692
    • Hoy, J.1    Gahan, M.2    Carr, A.3    Smith, D.4    Lewin, S.5    Wesselingh, S.6
  • 32
    • 80054834564 scopus 로고    scopus 로고
    • Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)
    • Feeney E, Chazallon C, O'Brien N, Meiffredy V, Goodall R, Aboulker JP, et al. Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial). HIV Med 2011; 12:602-609.
    • (2011) HIV Med , vol.12 , pp. 602-609
    • Feeney, E.1    Chazallon, C.2    O'Brien, N.3    Meiffredy, V.4    Goodall, R.5    Aboulker, J.P.6
  • 33
    • 37349070983 scopus 로고    scopus 로고
    • Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: Preliminary results from a large randomized clinical trial
    • Wester CW, Okezie OA, Thomas AM, Bussmann H, Moyo S, Muzenda T, et al. Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial. J Acquir Immune Defic Syndr 2007; 46:318-322.
    • (2007) J Acquir Immune Defic Syndr , vol.46 , pp. 318-322
    • Wester, C.W.1    Okezie, O.A.2    Thomas, A.M.3    Bussmann, H.4    Moyo, S.5    Muzenda, T.6
  • 34
    • 0041914142 scopus 로고    scopus 로고
    • Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns
    • Galli M, Veglia F, Angarano G, Santambrogio S, Meneghini E, Gritti F, et al. Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr 2003; 34:58-61.
    • (2003) J Acquir Immune Defic Syndr , vol.34 , pp. 58-61
    • Galli, M.1    Veglia, F.2    Angarano, G.3    Santambrogio, S.4    Meneghini, E.5    Gritti, F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.